Drug Pricing

Drug Pricing

Wayne Winegarden Featured in Newsweek Drug Pricing Story

Title: Big Pharma Backs Joe Biden, But People Don’t Think He’ll Fix Drug Pricing By Darragh Roche Former Vice President Joe Biden is winning the race for donations from Big Pharma but experts and industry stakeholders doubt his plans will successfully lower drug prices or address underlying issues in the ...
Drug Pricing

NEW BRIEF: Mandating that Drug Rebates Benefit Consumers Will Help Patients with High Out-of-Pocket Drug Costs

A new brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute found that reforms mandating drug rebates benefit patients rather than payers would lower overall health care costs and help patients with expensive out-of-pocket drug costs. Click here to download the brief “Ironically, ...
Blog

What We’re Watching – September 18

Tim Anaya – Making the Entire Health Care System More Affordable In the final episode in PRI’s “Escape the Drug Pricing Maze” series, the Professor and Pete visit the City of Free Enterprise and learn that reforms to make the entire health care system more affordable are critical to making ...
Commentary

Price Controls Are Disastrous For Rents And Will Be For Drugs

President Trump and senior advisor Jared Kushner claim that the most favored nation executive order signed by the President over the weekend is necessary for drug pricing because “the U.S. shouldn’t pay more than other European countries for the same treatments.” This policy will make things worse, not better. If the president ...
Commentary

Trump’s Drug Pricing Order Is A Costly Mistake

On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...
Commentary

California should not get into the drug manufacturing business

In an attempt to lower Californians’ prescription drug costs, lawmakers just passed a bill that would allow the state government to contract with pharmaceutical manufacturers to produce generic drugs. Gov. Gavin Newsom’s signature is all but guaranteed before the end of the month. Golden State politicians aren’t the only ones ...
Blog

California Entering Pharmaceutical Business Won’t Lower Drug Prices for Patients

The state of California, which can’t keep the lights on thanks to political interference in energy generation, nor build enough homes because government has poisoned the housing market, is going into the pharmaceutical manufacturing business. But there’s nothing to worry about. If it struggles, taxpayers will be there to bail ...
Blog

California’s Worst Bills of the Legislative Session

The final gavel fell last week on the 2020 legislative session.  Cut short by seven weeks due to the coronavirus, lawmakers were forced to take a backseat to Gov. Newsom, who made use of his wide-ranging emergency powers to lock down businesses to stop the spread of the virus and ...
Commentary

A Look At The Democrats’ Not-So-Moderate Healthcare Platform

At their virtual convention this week, Democrats went to great lengths to communicate that they were united in their quest to defeat President Trump. Health care would appear to be the exception to that spirit of unity. More than 700 delegates to the Democratic National Convention said beforehand they’d oppose ...
Blog

What We’re Watching – August 28

Ben Smithwick – Helping Citizens Understand a World without Fossil Fuels Ronald Stein, co-author of the new book Just GREEN Electricity – Helping Citizens Understand a World without Fossil Fuels, discusses the dangers of overreliance on renewable energy. Click here to watch the video Tim Anaya – Making Biosimilars and ...
Drug Pricing

Wayne Winegarden Featured in Newsweek Drug Pricing Story

Title: Big Pharma Backs Joe Biden, But People Don’t Think He’ll Fix Drug Pricing By Darragh Roche Former Vice President Joe Biden is winning the race for donations from Big Pharma but experts and industry stakeholders doubt his plans will successfully lower drug prices or address underlying issues in the ...
Drug Pricing

NEW BRIEF: Mandating that Drug Rebates Benefit Consumers Will Help Patients with High Out-of-Pocket Drug Costs

A new brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute found that reforms mandating drug rebates benefit patients rather than payers would lower overall health care costs and help patients with expensive out-of-pocket drug costs. Click here to download the brief “Ironically, ...
Blog

What We’re Watching – September 18

Tim Anaya – Making the Entire Health Care System More Affordable In the final episode in PRI’s “Escape the Drug Pricing Maze” series, the Professor and Pete visit the City of Free Enterprise and learn that reforms to make the entire health care system more affordable are critical to making ...
Commentary

Price Controls Are Disastrous For Rents And Will Be For Drugs

President Trump and senior advisor Jared Kushner claim that the most favored nation executive order signed by the President over the weekend is necessary for drug pricing because “the U.S. shouldn’t pay more than other European countries for the same treatments.” This policy will make things worse, not better. If the president ...
Commentary

Trump’s Drug Pricing Order Is A Costly Mistake

On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...
Commentary

California should not get into the drug manufacturing business

In an attempt to lower Californians’ prescription drug costs, lawmakers just passed a bill that would allow the state government to contract with pharmaceutical manufacturers to produce generic drugs. Gov. Gavin Newsom’s signature is all but guaranteed before the end of the month. Golden State politicians aren’t the only ones ...
Blog

California Entering Pharmaceutical Business Won’t Lower Drug Prices for Patients

The state of California, which can’t keep the lights on thanks to political interference in energy generation, nor build enough homes because government has poisoned the housing market, is going into the pharmaceutical manufacturing business. But there’s nothing to worry about. If it struggles, taxpayers will be there to bail ...
Blog

California’s Worst Bills of the Legislative Session

The final gavel fell last week on the 2020 legislative session.  Cut short by seven weeks due to the coronavirus, lawmakers were forced to take a backseat to Gov. Newsom, who made use of his wide-ranging emergency powers to lock down businesses to stop the spread of the virus and ...
Commentary

A Look At The Democrats’ Not-So-Moderate Healthcare Platform

At their virtual convention this week, Democrats went to great lengths to communicate that they were united in their quest to defeat President Trump. Health care would appear to be the exception to that spirit of unity. More than 700 delegates to the Democratic National Convention said beforehand they’d oppose ...
Blog

What We’re Watching – August 28

Ben Smithwick – Helping Citizens Understand a World without Fossil Fuels Ronald Stein, co-author of the new book Just GREEN Electricity – Helping Citizens Understand a World without Fossil Fuels, discusses the dangers of overreliance on renewable energy. Click here to watch the video Tim Anaya – Making Biosimilars and ...
Scroll to Top